My fair value estimate on a standalone-basis is €11.04/share. Gross spread to the increased consideration is 2.3%. Upside could come from an increased offer from Ion. Reiterate long CERV IM.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.